During the last 7 years, investigations on the subject have been increasing, and the work has been well summarized by Faget (1947) and Sharp and Payne (1948) . In the present article it is proposed to survey the present status of these drugs in the treatment of leprosy.
Historical Fromm and Wittmann (1908) (1937) , Fourneau et al. (1937) and Bauer and Rosenthal (1938) found that this substance had a great anti-bacterial power against streptococcal infection in mice and to some extent in rabbits and monkeys. Buttle et al. (1937) found that in man a single dose of 300 mg. Parke. Davis & Co. produced definite anti-bacterial effect in the blood. Later (quoted by Lowe, 1950 ) the drug was tried in human beings with acute infections, in doses of 1 to 2 gm. a day, but the treatment was soon abandoned because of the rapid production of met-haemoglobinsemia and other toxic effects. The drug was, therefore, not used for treatment of infection in man, though it has established itself as a powerful anti-bacterial agent in veterinary medicine. The interest in the drug was revived when Rist et al. (1940) showed its favourable effects in experimental tuberculosis in rabbits and guinea-pigs.
THE SULPHONE DRUGS USED IN LEPROSY
Because of the toxic effects of the diaminodiphenyl-sulphone various attempts have been made to produce a derivative which would be safe and effective.
The Feldman, Hinshaw and Moses (1940) regarding anti-tuberculous activity of the sulphones was followed by extensive trials of the parent compound and its derivatives in experimental tuberculosis in guinea-pigs, and of the derivatives in human tuberculosis. In this connection the work of Feldman and his associates stands out prominently; and information on the subject has been well summarized by Feldman (1946 Dharmendra and Chatterjee (1947) , Dharmendra (1948) (1948) reported on the use of promin solution intradermally into the nodules. Information on the use of promin is also found in the reviews on the sulphone drugs by Faget (1947), Faget and Erickson (1948) , Johansen and Erickson (1948) , and Sharp and Payne (1948) .
Toxicity.?When given by mouth promin was found to be very toxic. Hinshaw and Feldman (1941) reported that a dose of 1 to 3 gm. by mouth was attended with toxic symptoms. (Muir, 1946 (Muir, , 1947 found that it was well tolerated orally.
The oral route is now the routine method of administration of the drug. Faget and Pogge (1945) and Faget (1947) next reported from the Carville Leprosarium on the beneficial effects of diasone given orally in the doses of 1 gm. daily. Fernandez and Carboni (1946) , Dharmendra and Chatterjee (1947) , Dharmendra (1948) , Floch and Camain (1948) Wharton (1947) , Dharmendra and Chatterjee (1947) , Dharmendra (1948 , Davey (1948) , Davidson (1948) ^as low toxicity in prolonged ones. They coneluded that when given by mouth sulphetrone is the least toxic of the sulphones, and also less toxic than any of the sulphonamide drugs.
They reported that in rabbit the chronic haemato-toxic effects include a haemolytic anaemia, an anaemia of iron lack, and an anaemia of nutritional origin. reported that this was seen in man also. As a matter of fact haematological changes follow the administration of any of the sulphone drugs.
L
Absorption from the gut.?Sulphetrone as also diasone and the other sulphone derivatives given by mouth are very incompletely absorbed from the gut. (1) As judged by the height of blood concentration produced after a particular dose, maintenance of blood levels and longest period up to which the drug could be detected in the blood, the dose by the intramuscular route would be less than l|5th of the dose by the oral route.
(2) On the same considerations, as also because of ease of injection, the watery solution appears to be the best preparation, the emulsion in hydnocarpus oil and water being the next. The oily suspensions with or without the addition of wax offer no advantage since they do not possess any appreciable repository effect, but on the other hand these suspensions have certain disadvantages, as they are more difficult to inject and more likely to produce irritation, induration, etc., at the site of injection.
(3) The intramuscular administration of sulphetrone has a great advantage over the oral administration, as the intramuscular treatment is more economical and possibly more effective.
Dosage.?By the oral route the initial dose is 1 tablet 3 times a day (a total of 1.5 gm.) and this dose is gradually increased to a total dose of 12 tablets a day (6 gm. daily). At this rate the weekly dose for 6 days a week works out at 36 gm. per week.
By the intramuscular route a total dose of 4 gm. a week would suffice; this amount may be given in two doses of 2 gm. twice a week, or in smaller doses more frequently. [Aug., 1950 Blood concentration.? (a) After oral administration? Wharton (1947) Absorption from the gut.?Unlike its derivatives DDS is quickly and completely absorbed from the gut. Lowe and Smith (1948) and Smith (1949) yard-stick by which to measure improvement. ' In the tuberculoid case I am of opinion that sulphone therapy is decidedly harmful because it is liable to precipitate an acute tuberculoid reaction with all the dangers of nerve damage? through inflammatory reaction in the nerves possibly leading to abscess formation. ' Later, he (Cochrane, 1949a) As stated earlier the extensive use of the sulphone drugs in the leprosy institutions as also on out-patients is likely to make a definite contribution towards the control of the spread of leprosy.
